EGFR c.1035T>G ;(p.F345L)

Variant ID: 7-55224254-T-G

NM_005228.3(EGFR):c.1035T>G;(p.F345L)

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.

Bmc Cancer
Masago, Katsuhiro K; Fujita, Shiro S; Muraki, Miho M; Hata, Akito A; Okuda, Chiyuki C; Otsuka, Kyoko K; Kaji, Reiko R; Takeshita, Jumpei J; Kato, Ryoji R; Katakami, Nobuyuki N; Hirata, Yukio Y
Publication Date: 2015-11-16

Variant appearance in text: EGFR: F345L
PubMed Link: 26572169
Variant Present in the following documents:
  • Main text
  • 12885_2015_Article_1925.pdf
View BVdb publication page



Continuously tunable nucleic acid hybridization probes.

Nature Methods
Wu, Lucia R LR; Wang, Juexiao Sherry JS; Fang, John Z JZ; Evans, Emily R ER; Pinto, Alessandro A; Pekker, Irena I; Boykin, Richard R; Ngouenet, Celine C; Webster, Philippa J PJ; Beechem, Joseph J; Zhang, David Yu DY
Publication Date: 2015-12

Variant appearance in text: EGFR: F345L
PubMed Link: 26480474
Variant Present in the following documents:
  • NIHMS726951-supplement-1.pdf
View BVdb publication page



Kinome-wide decoding of network-attacking mutations rewiring cancer signaling.

Cell
Creixell, Pau P; Schoof, Erwin M EM; Simpson, Craig D CD; Longden, James J; Miller, Chad J CJ; Lou, Hua Jane HJ; Perryman, Lara L; Cox, Thomas R TR; Zivanovic, Nevena N; Palmeri, Antonio A; Wesolowska-Andersen, Agata A; Helmer-Citterich, Manuela M; Ferkinghoff-Borg, Jesper J; Itamochi, Hiroaki H; Bodenmiller, Bernd B; Erler, Janine T JT; Turk, Benjamin E BE; Linding, Rune R
Publication Date: 2015-09-24

Variant appearance in text: EGFR: F345L
PubMed Link: 26388441
Variant Present in the following documents:
  • mmc4.xlsx, sheet 1
View BVdb publication page



Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial.

British Journal Of Cancer
Le Tourneau, C C; Paoletti, X X; Servant, N N; Bièche, I I; Gentien, D D; Rio Frio, T T; Vincent-Salomon, A A; Servois, V V; Romejon, J J; Mariani, O O; Bernard, V V; Huppe, P P; Pierron, G G; Mulot, F F; Callens, C C; Wong, J J; Mauborgne, C C; Rouleau, E E; Reyes, C C; Henry, E E; Leroy, Q Q; Gestraud, P P; La Rosa, P P; Escalup, L L; Mitry, E E; Trédan, O O; Delord, J-P JP; Campone, M M; Goncalves, A A; Isambert, N N; Gavoille, C C; Kamal, M M
Publication Date: 2014-07-08

Variant appearance in text: EGFR: Phe345Leu
PubMed Link: 24762958
Variant Present in the following documents:
  • Main text
  • bjc2014211a.pdf
View BVdb publication page